A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma

• by Kartik Sehgal, Anthony Serritella, Mofei Liu, Anne ONeill, Chaitali Nangia, Theodora Pappa, Michael J Demeure, Francis P Worden, Robert I Haddad, Jochen Lorch

• June 29, 2024

A Novel Interpretable Machine Learning Method for Predicting Distant Metastasis in Papillary Thyroid Carcinoma: Development, Validation, and Clinical Implications

• by Ruijie Sun, Yuhui Ma, Yushan Jiang, Xiaoguang Li

• April 29, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

How AI Is Shaping Thyroid Disease Care

A new review finds AI is transforming thyroid disease care across imaging, pathology, and follow-up, but gaps in generalizability, transparency, and clinical integration persist.

• by Julia Cipriano, MS, CMPP

• February 5, 2026

• 4 min